Sinofert Holdings Limited Overview
Sinofert is the listed crop-nutrition platform of Sinochem Holdings. It is one of China's largest integrated fertilizer distributors and a core undertaker of the national potash commercial reserve. The business spans the whole chain: phosphate resources (about 200 Mt of phosphate rock reserves), 11 controlled or invested production enterprises, imports, distribution and agronomic service. Its moat is distribution reach. The network covers 96% of China's agricultural counties and includes more than 50,000 cooperative outlets, 150 warehouses and over 2.7 Mt of flexible storage. Sinofert also holds long-standing exclusive China import rights from global potash majors, including Canpotex and Arab Potash Company. Strategically, it is moving from a low-margin trading house toward a branded "Bio+" (biological fertilizer and soil-health) company. Biofertilizer volumes reached 1.54 Mt in FY2025, up 14%. Financially, the balance sheet holds net cash, ROE is about 11–12%, and dividends pay out about one-third of earnings. The main constraint is structurally thin gross margins of about 12%, set by a state-mandated "supply assurance and price stabilisation" role.
Company's own description (AR 2025, paraphrased)
In its FY2025 Annual Report, Sinofert presents itself as the core strategic operating entity for Sinochem Holdings' crop-nutrition business. It describes four roles:
-
a core undertaker of national potash commercial reserves;
-
a leading distributor of agricultural inputs in China;
-
a fertilizer business covering resources, R&D, production, distribution, retail and agronomic services;
-
a central SOE with a mandate to secure supply, stabilise prices and support national food security.
The stated vision is to become a leader in crop nutrition, working with farmers to "create fertile land." The core strategy is "Bio+": biotechnology-led products in three directions (nutrient efficiency, biological formulations/biofertilizers and soil health). These are supported by an "IPD" integrated R&D–production–marketing system and an online–offline marketing system.
Business model and revenue model
Sinofert's revenue is almost entirely product sales recognised at a point in time (Interim 2026, Note 3). It has no material subscription, licensing or service revenue. Agronomic services, soil testing and digital platforms (Nong Xiaohui, Nong Daquan, the 400 hotline) are bundled into the product proposition rather than monetised separately. There are three economic engines.
-
Strategic procurement and distribution (Basic Business). Sinofert imports and centrally procures potash, phosphate fertilizers and sulphur, then distributes them domestically and handles export trading. This is high-volume, low-margin trade (segment margin about 5%). Its value comes from exclusive supply contracts, scale logistics and the state reserve role.
-
Branded value-added fertilizers (Growth Business). Sinofert develops, makes (in-house or via toll partners) and markets bio-compound and specialty fertilizers under proprietary brands, including Lanlin, Kedefeng, Yaxin, Huanfeng, Zhiyang, Youliangmei and Songtian. It also distributes Syngenta Group crop-protection products and seeds through intra-group synergy. This is the strategic growth engine.
-
Upstream manufacturing (Production Business). Three plants:
-
Sinochem Yunlong (Yunnan): feed-grade MCP/DCP, integrated with its own phosphate mine;
-
Sinochem Fuling (Chongqing): phosphate fertilizers and refined phosphates;
-
Sinochem Changshan (Jilin): synthetic ammonia, urea and compound fertilizer.
-
Revenue mix by product (FY2025, AR 2025 Table 1)
| Product line | FY2025 revenue (CNY Mn) | % of total |
|---|---|---|
| Phosphate fertilizers | 7,512 | 32% |
| Compound fertilizers | 7,483 | 32% |
| Potash fertilizers | 4,195 | 18% |
| MCP/DCP (feed phosphates) | 1,571 | 7% |
| Special fertilizers | 434 | 2% |
| Others (incl. sulphur, crop protection, seeds, nitrogen) | 2,068 | 9% |
| Total | 23,263 | 100% |
Value-chain position, customers and end-markets
Value-chain position: a midstream aggregator with partial upstream integration. Upstream it has the Mozushao phosphate mine (Yunlong) and phosphate processing. Midstream it runs import, procurement and blending. Downstream it reaches retail through the cooperative-outlet network and digital channels.
Customer types: - compound-fertilizer manufacturers, the industrial channel buying potash and phosphates;
-
provincial and county-level distributors and agri-input dealers, including "KA" key accounts;
-
retailers and cooperative outlets;
-
large-scale growers and farmers, reached via demonstration fields (more than 3,000 in 2025) and the Nong Xiaohui online stores (more than 18,000);
-
feed manufacturers (MCP/DCP);
-
export customers (the "Others" geographic bucket).
End-markets: Chinese grain crops (rice, wheat, maize), cash crops (fruit, vegetables, tea, tobacco), animal feed (MCP/DCP) and some industrial phosphate uses. The H1 2026 interim mentions drip irrigation and new-energy niches for phosphates.
Independent characterisation
Sinofert is best understood as a state-anchored fertilizer distribution utility with a growing branded-product layer. Roughly half of external revenue (FY2025: 53%) is Basic Business trading, where margins are policy-capped. The investment case depends on three things:
-
whether the branded "Bio+" franchise can grow fast enough to lift the group gross margin from about 12% toward the high teens;
-
whether the volatile Production assets can be stabilised: Changshan lost RMB113 m in FY2025, while Yunlong earned RMB408 m;
-
whether cash generation continues to fund a rising dividend.
Sinofert is not a resource company in the Nutrien or Mosaic sense. Its mining exposure is limited to phosphate rock feeding Yunlong. Its earnings beta to global potash prices is muted because it acts mostly as an importer and distributor, not a producer.
Strategy
Stated strategy themes (AR 2025, Interim 2026), paraphrased except where quoted
"Bio+" strategic transformation: as the core. The company describes the structure as "Bio+" at the core, basic and production businesses as supports, and innovative businesses for value expansion.
Three R&D directions: nutrient efficiency, biological formulations and soil health.
"Product + Service + Technology": integrated marketing, reaching end-growers through digital platforms.
Operational excellence and green, low-carbon development: at plants: phosphogypsum utilisation, photovoltaic power, automation.
Central-SOE mandate: ensure supply, stabilise prices, support the Central Document No. 1 food-security goals (the "100 billion jin" grain capacity increase and the 1.4 trillion jin output anchor).
International expansion (new emphasis in AR 2025): steady expansion into international markets, optimised global procurement and sales networks, and deeper partnerships with global suppliers.
Vision (AR 2025): "becoming a leader in crop nutrition health."
H1 2026 headline themes: strict cost discipline, aggressive cost reduction, "expanding markets to increase revenue," and a "strong operation and control-oriented" headquarters.
Strategic initiatives, last 24 months (Oct 2024 – Oct 2026)
| Initiative | Date | Description / target | Status |
|---|---|---|---|
| Bio+ product launches | 2025–H1 2026 | Huanfeng, Zhiyang, Songtian, Jirun; Lanlin and Kedefeng upgrades; 20 new or upgraded products in 2025 and 17 initiated in H1 2026 | Ongoing; biofertilizer volume +14% (FY2025) and +11% (H1 2026) |
| R&D platform build-out | 2025–2026 | "Semi-field" biological testing platform (completed, operating). Advanced biological manufacturing flexible platform (under construction). 3 new R&D models (12 in total). | In progress |
| Key technology programme | 2025–2026 | 10 key technologies including biological nitrogen fixation, synthetic biology (CW2), and root-phosphorus-microbe integration for phosphorus-use efficiency | 3 at applied stage (2025); 2 at applied stage (H1 2026) |
| HOPE Soil Health platform | 2,025 | Saline-alkali and low-yield farmland solutions; launch event in Mar 2025 | 25 indicator systems |
| Digital marketing (Nong Xiaohui / Nong Daquan) | 2025–2026 | Online stores, private-domain user base, campaigns (5,993 in H1 2026) | Over 18,000 stores |
| Brand repositioning | Sep 2025 | Positioning as a leader in crop nutrition and health; new brand proposition launched at the CBP Bio-agriculture Conference | Done |
| Potash supply diversification | Sep–Nov 2025; H1 2026 | APC and Canpotex MOUs for 2026–2028; Dubai land-transport potash MOU; new supplier partnerships in H1 2026 | Executed |
| Yunlong Mozushao 2.2 Mtpa mining and processing project | 2025–2026 | Upstream phosphate-rock security | Preliminary work under way |
| Changshan transformation | 2025–2026 | High-tower compound line (1,000 t/d); CO₂ recycling; photovoltaic power | Commissioned Apr 2026 |
| Phosphogypsum utilisation | Ongoing | Yunlong 100%; Fuling 67.85% (2025) and 78.11% (H1 2026) | Ongoing |
| Green electricity | 2,025 | 28 m kWh of green and PV power purchased | Ongoing |
| Governance and systems | 2025–2026 | 124 internal systems published (2025); over 50 regulations revised (H1 2026); ERP upgrade and financial shared-services research; HQ restructuring | Ongoing |
| Cost programme | H1 2026 | Selling expenses −11.8%, administrative expenses −6.2% YoY | Delivered in H1 2026 |
Medium-term targets and guidance
Not publicly disclosed. Sinofert does not issue numerical revenue, margin or EPS guidance. The H1 2026 outlook is qualitative: a more complex and uncertain fertilizer market, with demand supported by grain-capacity policy and a good summer harvest.
Products & Services
Pricing is not publicly disclosed for any product. Sinofert sells at market or negotiated prices through distributors. All information below comes from AR 2025 and Interim 2026 unless stated otherwise.
Basic Business products
| Product / brand | Description | Target customer | Launch / latest | Notes |
|---|---|---|---|---|
| Imported potassium chloride (MOP) | Seaborne and rail potash for industrial compound-fertilizer makers and for agriculture | Compound-fertilizer producers; distributors | Ongoing; the 2026 China contract price was US$348/t CFR | Exclusive China rights for Canpotex (2026–2028 MOU, signed 5 Nov 2025) and APC (2026–2028 MOU, Sep 2025). A land-transport potash MOU was also signed with Food Safety Supply Chain Ltd (Dubai) in Nov 2025. |
| "Maple Harmony" red potash (Canpotex) | Canadian red granular potash, exclusive in China | Southern China growers | Renewed for 2026–2028 | Named in Tiger Brokers newswire, Nov 2025 |
| Fenghexiang (楓禾祥) | Agricultural potash channel brand | Retail and farmer channel | Core of the agricultural potash marketing model, per AR 2025 | Dual-core agricultural potash model alongside Weidefeng (Interim 2026) |
| Weidefeng (威得豐) | Biological potash fertilizer | Cash-crop and grain growers | Volumes grew in 2025; H1 2026 bio-potash sales 39 kt, +34% | One of the "Bio+" products |
| Meilinmei (美麟美) | Bio-phosphate (efficiency-enhanced phosphate) fertilizer series | More than 30 crop types | Launched 2018; H1 2026 volume +18% | Over 1.2 Mt cumulative sales and over 30 m mu served by end-2025. Recognised by SASAC as a central-SOE brand-creation achievement and as a "Sinochem Holdings TOP50 Brand" (Dec 2025). |
| Conventional phosphate fertilizers (MAP/DAP etc.) | Procured from strategic partners and own or JV plants | Distributors; compound-fertilizer makers | Ongoing | Revenue of RMB7,512 m in FY2025 (all segments) |
| Sulphur | Raw material trading | Phosphate processors | Ongoing | High exposure to price spikes; Yangtze port price above RMB10,000/t in Jun 2026 |
Growth Business products
| Product / brand | Description | Target | Launch / latest | Notes |
|---|---|---|---|---|
| Lanlin (藍麟) | Bio-compound fertilizer single core product | Field and cash crops | "Lanlin Upgrade" (root-inducing agent) launched H1 2026 | Class A product |
| Kedefeng (科得豐) | Bio-compound fertilizer | Rice and other grains | "Kedefeng Upgrade" (rice fertilizer) launched H1 2026 | Class A product |
| Yaxin (雅欣) | Bio-compound fertilizer | Cash crops | Cited as a strong performer in FY2023 | — |
| Huanfeng (煥豐) | Organic-inorganic fully water-soluble fertilizer | Cash crops; fertigation | Launched 2025 | Selected as a 2025 annual quality/brand case in the petroleum and chemical industry (Interim 2026) |
| Zhiyang (智養) | Bio-compound single core product | General | Launched 2025 | — |
| Youliangmei (優靚美) | High-end biological foliar fertilizer | Cash crops | FY2025 revenue and gross profit growth | Part of the "Liang You Yi Tian" foliar portfolio |
| Youcuilu (優翠露) | Foliar fertilizer | Cash crops | FY2025 growth | Part of the same portfolio |
| Songtian (頌甜) | Seaweed polymer phosphorus-potassium biostimulant | Cash and grain crops | Launched mid-2025 | Promotes fruit set, colour and sweetness, according to the company |
| Moli+ (摩力+) series | Specialty fertilizer series | Cash crops | FY2025 growth | — |
| High-concentration microbial inoculants / bio-agent barrel fertilizers | Biological agents | Soil-health users | Ongoing | Foliar plus Moli plus microbial combined volume of 53 kt in H1 2026 (+26%) |
| Jirun (激潤) | Specialty product based on patented "priming carbon" technology | Problem soils; grain and cash crops | Launched H1 2026 | Showcased at the Global Special Fertilizer Conference |
| Clear-liquid macronutrient water-soluble fertilizer (Changshan) | Liquid water-soluble fertilizer | Northeast China growers | Apr 2025 | Fills a high-end functional-fertilizer gap in Northeast China |
| Syngenta crop-protection synergy | Distribution of Syngenta Group pesticides/agrochemicals | Distributors and growers | Ongoing | FY2025 revenue RMB408 m; FY2022 RMB336 m (24% 3-year CAGR to 2022) |
| Seed synergy | Distribution of Syngenta Group China seed varieties (rice, maize, wheat) | Large growers | Ongoing | FY2025 revenue RMB51.77 m |
Production Business products
| Product | Producer | Capacity / output | Notes |
|---|---|---|---|
| Feed-grade MCP/DCP, including high-phosphorus MCP23 | Sinochem Yunlong (Xundian, Kunming, Yunnan) | FY2025 production and sales 350 kt. H1 2026 production 194.4 kt, sales 191.5 kt. | FY2025 net profit RMB408 m. Mozushao mine has a 2.2 Mtpa integrated mining and processing project under way. 100% phosphogypsum utilisation. |
| Phosphate fertilizers, finished acid, refined phosphates | Sinochem Fuling (Chongqing) | FY2025 fertilizer and finished acid output 1,110.2 kt (+114.1 kt). H1 2026: 454 kt. | Listed in the MIIT "2025 5G Factory Catalogue". Phosphogypsum utilisation 67.85% (FY2025) and 78.11% (H1 2026). |
| Synthetic ammonia, urea, compound/BB/water-soluble fertilizer | Sinochem Changshan (Songyuan, Jilin) | H1 2026 output 229.8 kt (+35.8%). High-tower compound fertilizer line at 1,000 t/day from Apr 2026. | FY2025 net loss of RMB113 m; ammonia price down RMB417/t YoY |
Services and digital platforms
| Platform / service | Description | Scale |
|---|---|---|
| Nong Xiaohui (農小惠) | Online retail-store platform | More than 18,000 online stores; over 90% county coverage (FY2025) |
| Nong Daquan (農達圈) | Digital marketing and service platform | Marketing campaigns reached over 3.2 m farmers (FY2025) |
| 400 service hotline | Farmer technical support | — |
| HOPE Soil Health platform (厚圃) | Soil diagnosis, improvement and sustainable management solutions | 25 soil-health indicator systems |
| Agronomic service force | Field technicians, demonstration fields, soil testing | More than 1,200 technicians; over 3,000 demonstration fields (2025) and over 2,500 (H1 2026); over 1,000 soil-testing interventions (2025) |
| New-media content | Live streams and short video | More than 5,000 pieces and over 30 m reach (FY2025). Over 200 live streams, over 1,200 videos and over 10 m reach (H1 2026). |
Financial Detail
Segment Overview
| Segment | Contents | Key products / entities |
|---|---|---|
Basic Business | Domestic distribution and export trading of strategically and centrally procured potash, phosphate fertilizers and sulphur. Fulfils the supply-assurance and price-stabilisation mandate. | Imported potash (Canpotex "Maple Harmony" red potash, APC and others). Agricultural potash brand Fenghexiang. Bio-potash Weidefeng. Phosphate fertilizers including Meilinmei bio-phosphate. Sulphur. |
Growth Business | Integrated R&D, production and marketing of bio-compound and specialty fertilizers. Domestic distribution of crop-protection products and seeds through synergy with Syngenta Group. | Lanlin, Yaxin, Kedefeng, Huanfeng, Zhiyang (bio-compound). Youliangmei, Youcuilu, Songtian, Moli+, Jirun, microbial inoculants (specialty). Syngenta crop protection and seeds. |
Production Business | Manufacturing and sale by three subsidiaries | Sinochem Yunlong (feed-grade MCP/DCP, Mozushao phosphate mine). Sinochem Fuling (phosphate fertilizers, refined phosphates). Sinochem Changshan (synthetic ammonia, urea, compound/BB/water-soluble fertilizer). |
Segment revenue (CNY Mn, gross incl. internal)
| Segment revenue (CNY Mn, gross incl. internal) | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Basic Business | 11,334 | 14,047 | 16,721 |
Growth Business | 7,845 | 10,855 | 11,330 |
Production Business | 2,549 | 5,293 | 5,965 |
Elimination | — | -8,929 | -10,753 |
Group revenue | 21,728 | 21,265 | 23,263 |
External revenue (CNY Mn)
| External revenue (CNY Mn) | FY2024 | FY2025 |
|---|---|---|
Basic Business | 10,868 | 12,394 |
Growth Business | 8,020 | 8,452 |
Production Business | 2,377 | 2,418 |
Segment profit (CNY Mn)
| Segment profit (CNY Mn) | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Basic Business | 678 | 645 | 874 |
Growth Business | 239 | 347 | 349 |
Production Business | 506 | 387 | 404 |
Total segment profit | — | 1,379 | 1,628 |
Derived metric (FY2025, calc.) | Basic | Growth | Production |
Segment profit margin on gross segment revenue | 5.2% | 3.1% | 6.8% |
Segment profit margin, FY2024 | 4.6% | 3.2% | 7.3% |
YoY growth, gross segment revenue | +19.0% | +4.4% | +12.7% |
YoY growth, external revenue | +14.0% | +5.4% | +1.7% |
YoY growth, segment profit | +35.5% | +0.6% | +4.4% |
Share of group external revenue, FY2025 | 53.3% | 36.3% | 10.4% |
Share of group external revenue, FY2024 | 51.1% | 37.7% | 11.2% |
Share of total segment profit, FY2025 | 53.7% | 21.4% | 24.9% |
Segment Revenue
| Metric | H1 2025 | H1 2026 | YoY |
|---|---|---|---|
Basic, external revenue | 7,557 | 8,511 | +12.6% |
Growth, external revenue | 5,857 | 6,252 | +6.7% |
Production, external revenue | 1,300 | 1,518 | +16.8% |
Basic, segment profit | 719 | 717 | −0.3% |
Growth, segment profit | 420 | 476 | +13.3% |
Production, segment profit | 301 | 302 | +0.2% |
Total segment profit | 1,439 | 1,495 | +3.9% |
Income Statement and Margin Analysis (%)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Revenue (CNY Mn) | 22,641 | 23,003 | 21,728 | 21,265 | 23,263 |
Revenue growth YoY (%) | 5.89 | 1.60 | -5.54 | -2.13 | 9.40 |
Gross profit (CNY Mn; FY2021 calc. from FY2022 +31.43%) | 1,960 | 2,576 | — | 2,544 | 2,893 |
Gross margin (%) | 8.66 | 11.20 | — | 11.96 | 12.44 |
Operating income (CNY Mn; roic.ai operating margin × revenue) | 722 | 1,313 | 1,043 | 1,019 | 1,514 |
Operating margin (%; roic.ai) | 3.19 | 5.71 | 4.80 | 4.79 | 6.51 |
D&A (CNY Mn; roic.ai depreciation) | 247 | 305 | 416 | 445 | 479 |
EBITDA (CNY Mn; calc. operating income + D&A) | 969 | 1,618 | 1,459 | 1,464 | 1,993 |
EBITDA margin (%; calc.) | 4.28 | 7.03 | 6.71 | 6.88 | 8.57 |
Pre-tax income (CNY Mn; FY21–23 per Stockopedia) | 900 | 1,187 | 846 | 1,224 | 1,549 |
Income tax (CNY Mn) | — | — | — | — | 275 |
Net profit attributable to owners (CNY Mn) | 867 | 1,117 | 626 | 1,061 | 1,259 |
Net profit attributable YoY (%) | — | 28.84 | -43.96 | 69.49 | 18.66 |
Net margin, attributable (%) | 3.83 | 4.86 | 2.88 | 4.99 | 5.41 |
Basic EPS (MYR Bn) | 0.1234 | 0.1590 | 0.0891 | 0.1511 | 0.1793 |
Diluted EPS (MYR Bn) | 0.1234 | 0.1590 | 0.0891 | 0.1511 | 0.1793 |
DPS declared for year (MYR Bn equivalent, incl. special) | — | 0.0557 | 0.0445 | 0.0745 | 0.0602 |
Sales volume (Mt) | 10.40 | — | — | 7.21 | 7.31 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Analysis
| Item | CNY Mn |
|---|---|
Pre-tax profit | 1,549 |
Plus finance costs | 45 |
Less share of JV/associate results (101 − 5) | 96 |
Profit from operations (calc.) | ≈1,498 |
Expense
| Expense | FY2024 | FY2025 | Change |
|---|---|---|---|
Selling and distribution | 608 | 621 | +2.1% |
Administrative | 757 | 784 | +3.6% |
Finance costs | 57 | 45 | −21.1% |
Other expenses and losses | 357 | 205 | −42.6% (2024 included the RMB168 m Yangmei loan ECL) |
Share of JV results | 187 | 101 | −46.0% (Three Circles-Sinochem down RMB89 m) |
Share of associate results | 36 | −5 | — |
Balance Sheet and Margin Analysis (%)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Total assets (CNY Mn) | 17,494 | 20,822 | 21,983 | 21,417 | 23,588 |
Total liabilities (CNY Mn) | 8,511 | 11,090 | 12,064 | 10,782 | 12,134 |
Total equity incl. NCI (CNY Mn; calc.) | 8,983 | 9,732 | 9,919 | 10,635 | 11,454 |
Equity attributable to owners (CNY Mn) | — | — | — | — | 11,224 |
Cash and cash equivalents (CNY Mn) | 1,314 | 3,356 | 3,907 | 3,104 | 2,928 |
Interest-bearing debt, total (CNY Mn) | — | — | — | 1,870 | 1,507 |
Debt due within 1 year (CNY Mn) | — | — | — | 899 | 849 |
Debt due after 1 year (CNY Mn) | — | — | — | 971 | 658 |
Net debt / (net cash) excl. time deposits (CNY Mn; calc.) | — | — | — | -1,234 | -1,421 |
Goodwill (CNY Mn) | — | — | — | 861 | 854 |
Inventories (CNY Mn) | — | — | — | 5,225 | 5,830 |
Current assets (CNY Mn) | 10,199 | 12,732 | 14,128 | 12,391 | 13,991 |
Working capital (CNY Mn; calc. CA − CL) | 3,041 | 3,208 | 3,496 | 2,786 | 2,689 |
Debt-to-equity (%; company definition) | — | — | — | 17.59 | 13.16 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Ratios (x)
| Item | 30 Jun 2026 (CNY Mn) |
|---|---|
Interest-bearing debt | 1,899 |
Cash | 2,722 |
Time deposits | 2,973 |
Equity attributable | 11,978 |
Total equity | 12,196 |
Current ratio | 1.39 |
Debt-to-equity | 15.57% |
Cash Flow
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Operating cash flow (CNY Mn; FY21–23 Stockopedia; FY24 derived; FY25 Investing.com) | 1,569 | 2,003 | 2,485 | 1,042 | 1,994 |
Dividends paid in year (CNY Mn; calc. DPS × shares) | — | — | 391 | 313 | 524 |
Share buybacks (CNY Mn) | 0 | 0 | 0 | 0 | 0 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
ROE (%; FY24–25 company-reported on attributable equity; FY22–23 calc. on total equity) | — | 11.94 | 6.37 | 10.55 | 11.64 |
ROA (%; calc. attributable profit / average assets) | 5.01 | 5.83 | 2.93 | 4.89 | 5.59 |
ROIC (%; calc. NOPAT / average debt+equity) | — | — | — | — | 9.8 |
Current ratio (x; FY24–25 company; FY21–23 calc.) | 1.42 | 1.34 | 1.33 | 1.29 | 1.24 |
Debt / equity (%; company) | — | — | — | 17.59 | 13.16 |
Net debt / EBITDA (x; calc., negative = net cash) | — | — | — | -0.84 | -0.71 |
Interest coverage (x; calc. operating income / finance costs) | — | — | — | 18.6 | 33.3 |
Asset turnover (x; calc.) | 1.31 | 1.20 | 1.02 | 0.98 | 1.03 |
Inventory turnover days (company, 360-day basis) | — | — | — | 107 | 99 |
Receivable turnover days (company) | — | — | — | 6 | 5 |
Payable days (calc. average trade and bills payables / COGS × 360) | — | — | — | — | 68 |
Cash conversion cycle (days; calc.) | — | — | — | — | 36 |
Revenue by customer location (CNY Mn)
| Revenue by customer location (CNY Mn) | H1 2025 | H1 2026 |
|---|---|---|
Mainland China | 14,132 | 15,549 |
Others (export, incl. Macao/HK/overseas) | 582 | 732 |
Total | 14,715 | 16,281 |
Derived Details
| Derived (calc.) | Mainland China | Others |
|---|---|---|
YoY growth, H1 2026 | +10.0% | +25.7% |
Share of revenue, H1 2025 | 96.0% | 4.0% |
Share of revenue, H1 2026 | 95.5% | 4.5% |
Product revenue (CNY Mn)
| Product revenue (CNY Mn) | FY2024 | FY2025 |
|---|---|---|
Phosphate fertilizers | 6,660 | 7,512 |
Compound fertilizers | 6,748 | 7,483 |
Potash fertilizers | 3,939 | 4,195 |
MCP/DCP | 1,322 | 1,571 |
Special fertilizers | 678 | 434 |
Others | 1,918 | 2,068 |
Product revenue (CNY Mn) (Half-Yearly)
| Product revenue (CNY Mn) | H1 2025 | H1 2026 |
|---|---|---|
Compound fertilizers | 5,167 | 5,604 |
Phosphate fertilizers | 4,362 | 4,922 |
Potash fertilizers | 2,988 | 3,068 |
MCP/DCP | 842 | 1,054 |
Special fertilizers | 313 | 306 |
Others | 1,044 | 1,328 |
Valuation Snapshot
| Metric | Value | Source / date |
|---|---|---|
Latest verified close | 1.255 | MarketScreener, 15 Sep 2026 |
1-week change | −10.04% | MarketScreener, 15 Sep 2026 |
3-month change | −14.04% | MarketScreener |
6-month change | −30.28% | MarketScreener |
YTD 2026 change | −16.89% | MarketScreener |
1-year change | −12.67% | Investing.com, late Jul 2026 |
52-week range | 1.19 – 2.07 | MarketScreener / Investing.com |
3-year range | 0.74 – 2.07 | MarketScreener |
5-year range | 0.74 – 2.07 | MarketScreener |
Average daily volume | about 26.4 m shares | Investing.com |
Valuation Snapshot by Multiple
| Multiple | Value | Basis |
|---|---|---|
P/E, FY2025 | 6.1x | EPS RMB0.1793 = HK$0.2064 |
P/E, TTM | 5.7x | TTM EPS RMB0.1898 = HK$0.2185 |
P/E, 2026e (consensus) | 5.79x | MarketScreener |
P/E, 2027e (consensus) | 5.12x | MarketScreener |
P/B | 0.64x | BVPS RMB1.705 = HK$1.963 (30 Jun 2026, attributable) |
EV (cash only) | about RMB7.05 bn | Market cap RMB7.66 bn + debt 1.90 + NCI 0.22 − cash 2.72 |
EV (incl. time deposits) | about RMB4.05 bn | Also deducting RMB2.97 bn of time deposits and restricted cash |
EV/EBITDA, FY2025 | 3.5x (cash only); 2.0x (incl. deposits) | EBITDA RMB1,993 m (calc.) |
EV/Sales, TTM | 0.28x (cash only); 0.16x (incl. deposits) | TTM revenue RMB24,829 m |
EV/Sales, 2026e | 0.31x | MarketScreener |
Dividend yield, trailing | 5.5% | HK$0.0693 / HK$1.255 |
Dividend yield, 2026e / 2027e | 6.09% / 6.64% | MarketScreener consensus |
Dividend (per share)
| Dividend (per share) | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
Final dividend (MYR Bn equivalent) | 0.0557 | 0.0445 | 0.0521 | 0.0602 |
Special dividend (MYR Bn equivalent) | 0 | 0 | 0.0224 | 0 |
Total (MYR Bn equivalent) | 0.0557 | 0.0445 | 0.0745 | 0.0602 |
Payout ratio (%; calc.) | 35.0 | 49.9 | 49.3 | 33.6 |
Debt (CNY Mn)
| Debt (CNY Mn) | 31 Dec 2024 | 31 Dec 2025 | 30 Jun 2026 |
|---|---|---|---|
Due within 1 year | 899 | 849 | 1,308 |
Due after 1 year | 971 | 658 | 591 |
Fixed rate | 672 | 378 | 833 |
Floating rate | 1,198 | 1,129 | 1,066 |
Banking facilities (total) | — | 17,633 | 18,823 |
Banking facilities (unutilised) | — | 13,424 | 14,891 |
Analyst Conclusions
Management guidance
Qualitative only (Interim 2026 Outlook):
-
The fertilizer industry is entering a more complex and uncertain phase with divergent product trends.
-
Domestic demand should benefit from grain-capacity policies, a bumper summer harvest and stable autumn planting area.
-
H2 2026 priorities are technology and product upgrading, channel optimisation, prudent risk management and cost discipline.
-
AR 2025 adds that industry consolidation is expected to accelerate and that raw-material cost increases pose significant challenges in 2026.
Consensus expectations
-
MarketScreener-implied 2026e EPS growth: about +6% (P/E falls from 6.1x trailing to 5.79x 2026e at a constant price).
-
2027e: about +13% (P/E 5.12x).
-
Consensus EV/Sales of 0.31x (2026e) and 0.29x (2027e) implies modest revenue growth.
-
Single-analyst target: HK$2.015, about 61% upside versus HK$1.255.
Bull case
-
Mix-driven margin rerating. Gross margin rose about 380 bp over FY2021–FY2025, and Growth segment profit rose 13.3% in H1 2026 on 28% growth in high-end Bio+ volume. If biologicals keep compounding at 10–15% a year, group gross margin could reach the mid-teens. At 0.64x book and 5.7x TTM earnings, that improvement is not priced in.
-
Cash-rich, under-distributed balance sheet. Net cash including time deposits is about RMB4.7 bn, roughly 60% of market cap. The payout ratio is only about 34% (FY2025), and the 2025 special dividend shows willingness to distribute more. A move to 50% payout would lift the yield to about 8%.
-
Secured supply into a tight potash market. Exclusive Canpotex and APC supply runs to 2028 at a low 2026 contract price (US$348/t). Combined with the reserve role, this underpins Basic segment profit, which rose 35.5% in FY2025.
Bear case
-
Cost squeeze is structural, not cyclical. H1 2026 gross profit was flat on 10.6% revenue growth. Underlying profit was roughly flat once the RMB149 m impairment reversal is excluded. Fuling and the phosphate JVs are loss-making at record sulphur prices, and the price-stabilisation mandate limits pass-through.
-
SOE mandate caps returns. ROE of 10–12% and a net margin of about 5% reflect a policy-first business. Minority shareholders sit behind national food-security priorities, and connected transactions with Sinochem (leases, finance services, intra-group loans) dilute governance appeal.
-
Flat volumes and inventory risk. Volume fell 3.38% in H1 2026. Inventories reached RMB6.4 bn with unit costs up about 10%, so a price downturn in H2 2026 would force write-downs. Revenue CAGR of 0.7% over five years shows no structural top-line growth.
Catalysts and monitorables (next 12 months)
Late Oct 2026: 9M 2026 operating data. Watch whether net profit growth holds without the H1 one-off.
Sulphur, phosphate and potash prices: through the Q4 2026 winter storage season. Watch JV results (Three Circles-Sinochem) and Fuling.
2027 China potash contract negotiation: (typically late Q4 or early Q1). The 2026 price was US$348/t CFR.
FY2026 results (around late Mar 2027): dividend quantum and any special. Watch whether payout rises above about 34%.
New Chairman Zhang Xuegong's strategic agenda: Possible asset injections or reorganisation within Sinochem's agriculture and chemicals portfolio (unconfirmed).
Phosphate export-quota policy: and fertilizer reserve releases ahead of spring 2027.
Mozushao 2.2 Mtpa project: milestones; Changshan's return to sustained profitability.
Pillar Two top-up tax assessment: - Details of the 30 Jun 2026 lease framework agreement and any other connected transactions.
Analyst verdict
Sinofert is a cheap, cash-rich, policy-anchored fertilizer distributor that is slowly becoming a branded crop-nutrition company. At about HK$1.26 it trades near 0.64x book and under 6x trailing earnings. On a cash-only basis, EV is about 3.5x FY2025 EBITDA; on a gross-cash basis, about 2x. The dividend yields about 5.5%. Few Hong Kong-listed agricultural names look this inexpensive on balance-sheet-adjusted metrics.
The fundamental record supports the transformation story. Gross margin expanded from under 9% to over 12% in four years while low-margin volume was deliberately exited. Biologicals now exceed 1.5 Mt a year. Exclusive potash supply has been locked in through 2028.
The discount is not irrational, however. Revenue has not grown on a five-year view. Margins remain policy-capped because the company must stabilise domestic prices during shortages. Earnings quality is noisy: in FY2023, FY2024 and H1 2026, associate shutdowns, provisions and reversals swung results by RMB150–500 m. H1 2026 also showed that a raw-material shock, here sulphur, can stall gross profit even when revenue rises 10%.
The sharp share-price decline since March 2026 (−30% over six months) reflects these concerns. It also leaves the stock pricing in little of the Bio+ progress.
Verdict. The risk-reward for patient, income-oriented investors is constructive, with the dividend as downside protection. A rerating requires one of three things:
-
a visible step-up in payout, toward 50%;
-
evidence that Growth segment margins can expand through an input-cost spike;
-
a clear capital-allocation agenda from the new Chairman.
Absent these, Sinofert is likely to remain a value-trap-adjacent SOE yield play. Key downside triggers are a Q4 2026 fertilizer price correction that forces inventory write-downs, and further phosphate JV losses.
Stance (analyst, not investment advice): Accumulate on weakness for yield, with a 12-month view anchored to the HK$1.6–2.0 range observed over the past year. The single published target is HK$2.015.
Appendix: Source register
-
Sinofert Holdings, Annual Report 2025 (HKEXnews, 27 Apr 2026): https://www.hkexnews.hk/listedco/listconews/sehk/2026/0427/2026042700634.pdf
-
Sinofert, Interim Results Announcement H1 2026 (25 Aug 2026): https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0825/2026082500229.pdf
-
Sinofert, Interim Results Announcement H1 2025 (25 Aug 2025): https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0825/2025082500327.pdf
-
Sinofert, Interim Report 2025 (11 Sep 2025): https://www.hkexnews.hk/listedco/listconews/sehk/2025/0911/2025091100434.pdf
-
Sinofert, FY2024 Annual Results Announcement (25 Mar 2025): https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0325/2025032500195.pdf
-
Sinofert, FY2023 Annual Results Announcement (25 Mar 2024): https://www1.hkexnews.hk/listedco/listconews/sehk/2024/0325/2024032500607.pdf
-
Sinofert, FY2022 Annual Results Announcement (20 Mar 2023): https://www1.hkexnews.hk/listedco/listconews/sehk/2023/0320/2023032000309.pdf
-
Sinofert, FY2021 Annual Results Announcement (22 Mar 2022): https://www1.hkexnews.hk/listedco/listconews/sehk/2022/0322/2022032201120.pdf
-
Sinofert, Canpotex MOU connected-transaction announcement (10 Jul 2023): https://www1.hkexnews.hk/listedco/listconews/sehk/2023/0710/2023071000412.pdf
-
Sinofert, Name-change announcement (21 Dec 2006): https://www1.hkexnews.hk/listedco/listconews/sehk/2006/1222/ltn20061222059.pdf
-
Sinofert, Annual Report 2005/2006 extracts (HKEXnews)
-
PotashCorp, Form 8-K (2005) and Form 10-K FY2005 (SEC EDGAR)
-
Nutrien, Form 6-K (Q1 2025, Q3 2025, FY2024) and Form 40-F FY2025 (SEC EDGAR)
-
FilingReader: H1 2026 results summary (25 Aug 2026); FY2025 dividend (13 May 2026)
-
Tiger Brokers newswire: H1 2025 stock move; 9M 2025 data; Canpotex MOU (Nov 2025); FY2025 dividend (Mar 2026)
-
Argus Media: APC–Sinofert MOP agreement 2026–28 (15 Sep 2025)
-
MarketScreener (UK): share price, consensus P/E and yield (15 Sep 2026)
-
Investing.com: historical prices, balance-sheet and cash-flow aggregates, price target (2026)
-
Simply Wall St: dividends, earnings-miss notes, AGM dates
-
roic.ai: multi-year operating margin, depreciation, per-share data
-
Stockopedia: FY2019–FY2023 balance-sheet and cash-flow aggregates
-
Fintel (Capital IQ): FY2021–FY2025 assets, liabilities, cash
-
TipRanks: peer snapshot and hedge-fund data
-
Western Sahara Resource Watch: letter to Nutrien (22 Jan 2019)
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Role | Appointed | Age (AR 2025) | Education | Prior roles (summary) |
|---|---|---|---|---|---|
Zhang Xuegong | Executive Director; Chairman; Chair of Strategy Committee | Feb 2026 | 55 | MSc Physical Chemistry, Tsinghua (1995); MBA, CEIBS (2004) | Joined China Chemical Import & Export Corp. in 1995. Head of Sinochem Holdings' strategic execution department. GM of China National Seed Group. Oct 2022–Feb 2026: president of Sinochem Holdings' chemical division and GM/chairman of Sinochem International (600500.SH). Worked at Sinofert 1999–2001. |
Wang Tielin | Executive Director; CEO; Chair of Corporate Governance Committee | Jun 2024 | 58 (MarketScreener lists 59) | BEng and MEng Mechanical Engineering, Tsinghua | Former Tsinghua lecturer. Sinochem since 2002 (trust, tendering, agriculture division VP). Deputy party secretary and VP of Syngenta Group China. Sinofert Deputy GM 2006–2012. |
Chen Shengnan | Executive Director; Deputy GM | Jun 2024 (Deputy GM since May 2020) | 47 | BSc Chemistry and MSc Polymer Physics, Nankai | Joined Sinochem Fertilizer in 2003; ran the potash department. GM of the Sinochem Group fertilizer import department. Chair of Yitong Digital Technology. Director of Qinghai Salt Lake Industry (000792.SZ). |
Wang Ling | Executive Director; CFO | ED Mar 2023; CFO Feb 2023 | 51 | BA International Accounting and MA Accounting, Renmin University | Sinochem Group tax and accounting roles 2003–2021. Head of Sinochem Holdings tax management 2021–2023. |
Zhang Guangyan | Non-executive Director; Audit Committee member | 25 Aug 2025 | 51 | BEcon (1996) and Master of Business Management (2014), UIBE | Sinochem risk management, discipline inspection and audit roles. Sinochem Fertilizer deputy GM roles 2003–2011. Director of Cangzhou Dahua (600230.SH) and Sinochem Capital. |
Ko Ming Tung, Edward | INED; Chair of Nomination Committee | Apr 2000 | 65 | LLB (External), University of London | Principal of Edward Ko & Co., solicitors. INED of EverChina, Chia Tai Enterprises and China Vered Financial. |
Lu Xin | INED; Chair of Remuneration Committee | Feb 2015 | 62 | BEcon, Dongbei University of Finance & Economics; MBA, University of South Australia | Ministry of Finance 1987–1992. Golden Sino (Holdings) MD. Former ED, deputy chairman and MD of the company's predecessor 2001–2004. |
Sun Po Yuen, JP | INED; Chair of Audit Committee | Jun 2024 | 65 | Professional Diploma in Accountancy, HK Polytechnic | PwC partner 1996–2021 and global board member. HKEX Listing Committee 2009–2014. INED of Nine Dragons Paper, Jolimark and Nameson. |
Board of Directors — Wang Fang
| Name | Title | Age | Background |
|---|---|---|---|
Wang Fang | Deputy GM; GM of Phoschem division | 53 | Wengfu Group sales. Sinochem Fertilizer phosphate department GM. Deputy GM since May 2020. |
Shi Guangzhu | Deputy GM; QHSE Director; Chair of Sinochem Changshan | 43 | Sinochem Hebei. HSE director at Sinochem International and Syngenta Group China. Deputy GM since Jun 2024. |
Lai Ying Tung | Company Secretary | n.v. | Appointed Nov 2025 by written resolution, a disclosed deviation from CG Code C.6.2 |
Directors' Remuneration
| Committee | Chair | Members |
|---|---|---|
Audit (est. 1999) | Sun Po Yuen | Ko Ming Tung, Lu Xin, Zhang Guangyan |
Remuneration (est. 2005) | Lu Xin | Ko Ming Tung, Sun Po Yuen |
Nomination (est. 2005) | Ko Ming Tung | Lu Xin, Sun Po Yuen, Wang Ling |
Corporate Governance (est. 2012) | Wang Tielin | Chen Shengnan, Wang Ling |
Strategy (est. Jan 2024) | Zhang Xuegong | Wang Tielin, Chen Shengnan, Wang Ling, Lu Xin |
Board & Management Changes
| Date | Change |
|---|---|
Feb 2023 | Wang Ling appointed CFO (ED from Mar 2023) |
Jun 2024 | Wang Tielin appointed CEO and ED. Chen Shengnan appointed ED. Sun Po Yuen appointed INED. Shi Guangzhu appointed Deputy GM. |
Jun 2025 | Wang Ling joins Nomination Committee |
25 Aug 2025 | Zhang Guangyan appointed NED and Audit Committee member |
Nov 2025 | New Company Secretary (Lai Ying Tung) |
13 Feb 2026 | Su Fu resigns as Chairman and NED. Zhang Xuegong appointed ED and Chairman. Zhang previously ran Sinochem International, which suggests closer integration with Sinochem's chemicals platform. |
Major Shareholders
| Holder | Shares | Stake | Notes |
|---|---|---|---|
Sinochem Hong Kong (Group) Company Limited (ultimate: Sinochem Holdings) | 3,698,660,874 | 52.65% | Received from Syngenta Group (HK) on 23 Dec 2025 |
Nutrien Ltd. (formerly PotashCorp) | 0 | 0% | Held about 22% until 2024 (19% at 31 Dec 2024). Fully exited Q1 2025; Nutrien reported gross divestiture proceeds of US$193 m in FY2025. |
Public float | about 3.33 bn | about 47.3% | MarketScreener free-float figure: 47.28% |
Competitive Landscape
Competitors by Segment
| Segment | Competitor | Listing | Competitive overlap |
|---|---|---|---|
Basic (potash import/distribution) | China National Agricultural Means of Production Group (中農集團) | Unlisted SOE | Fellow member of the national potash import negotiation group; reserve undertaker |
Basic (potash) | Qinghai Salt Lake Industry | 000792.SZ | Largest domestic potash producer; competes with imported supply and is also a partner (Sinofert's Chen Shengnan sits on its board) |
Basic (potash) | Asia-Potash International (亞鉀國際) | 000893.SZ | Laos-sourced potash into China |
Basic / Production (phosphate) | Yuntianhua (雲天化) | 600096.SH | Largest Chinese phosphate fertilizer producer, integrated with mines; also an MCP/DCP competitor |
Basic / Production (phosphate) | Guizhou Phosphate Chemical / Kailin Group | Unlisted (Sinofert holds equity securities in Kailin) | Integrated phosphate producer |
Production (phosphate / refined) | Hubei Xingfa Chemicals | 600141.SH | Phosphate chemicals, refined phosphates |
Production (phosphate) | Hubei Yihua Chemical | 000422.SZ | Phosphate fertilizers |
Growth (compound) | Stanley Agriculture Group (史丹利) | 002588.SZ | Branded compound fertilizers |
Growth (compound / specialty) | Kingenta Ecological Engineering (金正大) | 002470.SZ | Compound, controlled-release and water-soluble fertilizers |
Growth (compound) | Xinyangfeng Agricultural Technology (新洋豐) | 000902.SZ | Phosphate-compound fertilizers |
Production (nitrogen) | China XLX Fertiliser | 1866.HK | Urea and compound fertilizers; competes with Changshan |
Production (nitrogen) | China BlueChemical | 3983.HK | Urea, phosphates and methanol |
Global context | Nutrien, Mosaic, Yara, ICL, K+S | NYSE/TSX/OSE/TASE/XETRA | Suppliers or competitors in specialty and biologicals; Yara and ICL are active in China specialty fertilizers |
Peer Comparison FY2025
| Metric | Sinofert (FY2025) | China BlueChemical | China XLX Fertiliser | Yuntianhua |
|---|---|---|---|---|
Revenue | RMB23,263 m | n.v. | n.v. | n.v. |
Revenue growth | +9.4% | n.v. | n.v. | n.v. |
Gross margin | 12.4% | n.v. | n.v. | n.v. |
Operating margin | about 6.5% | n.v. | n.v. | n.v. |
Net margin (attributable) | 5.4% | n.v. | n.v. | n.v. |
R&D intensity | — | n.v. | n.v. | n.v. |
Market cap | about HK$8.8 bn (Sep 2026) | about HK$10.8 bn (TipRanks snapshot) | about HK$10.1 bn (TipRanks snapshot) | n.v. |
“—” = not publicly disclosed.



